Diabetic Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Muscle and Bone in Patients with Diabetes Mellitus and Neuropathy
A recruiting clinical trial at University Hospital Ghent is investigating muscle and bone health in adults with type 2 diabetes and diabetic…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Whole-Body Vibration Versus Kineso Tape on Nerve Conduction in Patient With Diabetic Peripheral Neuropathy [NA]
The completed clinical trial compared whole-body vibration to kinesio tape for nerve conduction outcomes in patients with diabetic periphera…
-
FDA approval · 2024-08-23FDA Approved: PREGABALIN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for pregabalin from Solco Healthcare US, LLC, granting approval for changes related to the generic p…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Diabetes, Falls, and Fractures
The document reports completion of a clinical trial at Aalborg University Hospital examining diabetic peripheral neuropathy and diabetes wit…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Balance Control and Recovery in Diabetes Peripheral Neuropathy [NA]
The clinical trial update shows a study on balance control and recovery in diabetic peripheral neuropathy that is currently recruiting. No r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05). [Phase 2]
A Phase 2 study (NP05) evaluating LY3857210 in diabetic peripheral neuropathic pain has completed, with results posted in August 2024.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)
A pediatric proteomics study on Type 1 diabetes at Aristotle University of Thessaloniki is currently recruiting participants. The study uses…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Corneal Nerves Function and Structure [NA]
This clinical trial update examines corneal nerve function and structure in diabetic peripheral neuropathy. The study is completed and resul…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
This clinical trial is recruiting to characterize and predict early-onset diabetic peripheral neuropathy, including small fiber involvement,…
-
FDA approval · 2024-06-05FDA Approved: PREGABALIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves the supplemental ANDA for pregabalin from Aurobindo Pharma Limited, enabling the marketing of a generic pregabalin product in t…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy [NA]
Clinical trial investigating electroacupuncture for sensitive symptoms of distal diabetic peripheral neuropathy; the study is currently recr…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Effects of Multisystem Exercise on Balance, Postural Stability, Mobility and Pain in Patients With DPN. [NA]
The clinical trial assessing the effects of multisystem exercise on balance, postural stability, mobility, and pain in diabetic peripheral n…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy [NA]
This clinical trial compares needle-free subcutaneous injection versus conventional intramuscular injection of mecobalamin for diabetic peri…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Comparative Effects of Propioceptive Neuromascular Facilitation and Neural Flossing in Diabetic Neuropathy [NA]
This clinical trial is currently recruiting to compare proprioceptive neuromuscular facilitation and neural flossing as interventions for di…
-
FDA approval · 2024-01-24FDA Approved: PREGABALIN — Supplemental Application (MARKSANS PHARMA LIMITED)
FDA approved a supplemental application for pregabalin submitted by Marksans Pharma Limited (ANDA 216197).
-
FDA approval · 2023-12-13FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) from Pfizer's Parke-Davis division.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain [Phase 2]
Phase 2 trial updates safety and efficacy of BAY2395840 in diabetic neuropathic pain due to diabetic peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy [Phase 4]
Phase 4 clinical trial investigating the impact of related blood markers on diabetic peripheral neuropathy outcomes.
-
FDA approval · 2023-07-21FDA Approved: PREGABALIN — Supplemental Application (Eskayef Pharmaceuticals Limited)
FDA approved a supplemental application for pregabalin (generic) submitted by Eskayef Pharmaceuticals Limited.
-
FDA approval · 2023-06-26FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for pregabalin under ANDA 207623, indicating approval of changes to this gene…
-
FDA approval · 2023-06-21FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for pregabalin from Ascend Laboratories, LLC (ANDA207799), indicating approval of a supplemental fil…
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a generic pregabalin from Rising Pharma Holdings, Inc., authorizing its marketing for the same i…
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin from Alembic Pharmaceuticals Inc., enabling a generic version to be marketed.
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for pregabalin from Dr. Reddy's Laboratories Inc., authorizing a generic version under the approved …
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN CAPSULES, CV — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for Pregabalin Capsules, CV, enabling the marketing of a generic pregabalin capsule p…